Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BHAVANA REBBA

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1043261746
CMS profile
46636
Location
EDISON, NJ

General Payments · PY2018–2024

$2,320.87

  • Reported across 141 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$691.34

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $691.34 38

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $131.43 11
PY2019 $199.18 14
PY2020 $67.91 5
PY2021 $137.78 9
PY2022 $560.11 28
PY2023 $533.12 36
PY2024 $691.34 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABIOMED $43.12 12/02/2024 Food and Beverage Undisputed 01/23/2026 1142218674 CMS
ACADIA Pharmaceuticals Inc $15.22 06/21/2024 Food and Beverage Undisputed 01/23/2026 1147988749 CMS
Amgen Inc. $15.19 01/26/2024 Food and Beverage Undisputed 01/23/2026 1117361770 CMS
Amgen Inc. $15.43 05/17/2024 Food and Beverage Undisputed 01/23/2026 1117361772 CMS
ATRICURE, INC. $35.19 09/16/2024 Food and Beverage Undisputed 01/23/2026 1132889834 CMS
ATRICURE, INC. $33.55 12/16/2024 Food and Beverage Undisputed 01/23/2026 1132865755 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13.97 11/18/2024 Food and Beverage Undisputed 01/23/2026 1117848459 CMS
Eisai Inc. $17.00 02/02/2024 Food and Beverage Undisputed 01/23/2026 1110733564 CMS
Eisai Inc. $15.94 04/26/2024 Food and Beverage Undisputed 01/23/2026 1110733569 CMS
Eisai Inc. $17.00 05/31/2024 Food and Beverage Undisputed 01/23/2026 1110733575 CMS
Eisai Inc. $17.00 06/28/2024 Food and Beverage Undisputed 01/23/2026 1110733577 CMS
Eisai Inc. $14.93 07/17/2024 Food and Beverage Undisputed 01/23/2026 1110733573 CMS
Eisai Inc. $17.27 08/14/2024 Food and Beverage Undisputed 01/23/2026 1110733571 CMS
Eisai Inc. $17.27 08/26/2024 Food and Beverage Undisputed 01/23/2026 1110733566 CMS
Eisai Inc. $17.42 12/09/2024 Food and Beverage Undisputed 01/23/2026 1110733579 CMS
GlaxoSmithKline, LLC. $16.37 06/07/2024 Food and Beverage Undisputed 01/23/2026 1115871613 CMS
Janssen Pharmaceuticals, Inc $17.42 03/19/2024 Food and Beverage Undisputed 01/23/2026 1078089690 CMS
Lilly USA, LLC $13.49 01/12/2024 Food and Beverage Undisputed 01/23/2026 1136072035 CMS
Lilly USA, LLC $19.03 04/06/2024 Food and Beverage Undisputed 01/23/2026 1136014651 CMS
Lilly USA, LLC $21.42 05/29/2024 Food and Beverage Undisputed 01/23/2026 1136068746 CMS
Lilly USA, LLC $22.46 07/10/2024 Food and Beverage Undisputed 01/23/2026 1136014653 CMS
Lundbeck LLC $13.41 08/16/2024 Food and Beverage Undisputed 01/23/2026 1145960056 CMS
Lundbeck LLC $19.00 11/20/2024 Food and Beverage Undisputed 01/23/2026 1145960058 CMS
Novartis Pharmaceuticals Corporation $18.20 02/10/2024 Food and Beverage Undisputed 01/23/2026 1087309887 CMS
Novartis Pharmaceuticals Corporation $13.63 03/01/2024 Food and Beverage Undisputed 01/23/2026 1087309889 CMS
Novartis Pharmaceuticals Corporation $13.14 05/03/2024 Food and Beverage Undisputed 01/23/2026 1087309941 CMS
Novartis Pharmaceuticals Corporation $17.27 07/12/2024 Food and Beverage Undisputed 01/23/2026 1087309949 CMS
Novartis Pharmaceuticals Corporation $15.05 09/25/2024 Food and Beverage Undisputed 01/23/2026 1087309957 CMS
Novo Nordisk Inc $15.76 01/06/2024 Food and Beverage Undisputed 01/23/2026 1097789931 CMS
Novo Nordisk Inc $15.51 03/09/2024 Food and Beverage Undisputed 01/23/2026 1097668576 CMS
Novo Nordisk Inc $15.24 04/12/2024 Food and Beverage Undisputed 01/23/2026 1097735746 CMS
Novo Nordisk Inc $15.87 10/25/2024 Food and Beverage Undisputed 01/23/2026 1096586241 CMS
Novo Nordisk Inc $15.97 11/15/2024 Food and Beverage Undisputed 01/23/2026 1097616458 CMS
Novo Nordisk Inc $15.51 12/07/2024 Food and Beverage Undisputed 01/23/2026 1097797004 CMS
Otsuka America Pharmaceutical, Inc. $14.56 01/19/2024 Food and Beverage Undisputed 01/23/2026 1118967681 CMS
Otsuka America Pharmaceutical, Inc. $15.83 02/23/2024 Food and Beverage Undisputed 01/23/2026 1118967683 CMS
Otsuka America Pharmaceutical, Inc. $27.21 04/19/2024 Food and Beverage Undisputed 01/23/2026 1118967685 CMS
Otsuka America Pharmaceutical, Inc. $14.49 07/24/2024 Food and Beverage Undisputed 01/23/2026 1118967687 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.